What drove 4597.T stock to be most active pre-market?

High pre-market volume of **36,662,800** shares and upcoming clinical and earnings catalysts pushed 4597.T stock into the most-active list. Traders are reacting to pipeline news cadence and liquidity shifts ahead of the 20 May 2026 earnings announcement.

How does Solasia's valuation compare within healthcare?

4597.T stock shows stretched valuation: P/S **20.87** and P/B **5.49**, well above healthcare averages such as sector PE near **24.02**. That gap reflects revenue scale limits and expectation risk tied to clinical outcomes.

What is Meyka AI's short-term forecast for 4597.T stock?

Meyka AI's model projects a monthly level at **JPY 32.39** and a yearly projection of **JPY 25.66**, implying near-term flat movement but possible downside over 12 months. Forecasts are model-based and carry uncertainty; they are not guarantees.

JP Stocks

4597.T Solasia Pharma (JPX) pre-market: JPY 32.00 most-active on 13 Mar 2026, catalysts ahead

ByDanny Kontos March 13, 2026

The most active pre-market mover is 4597.T stock, trading at JPY 32.00 on 13 Mar 2026 as Asia healthcare names pick up volume. Trade activity is heavy with 36,662,800 shares changing hands against an average of 32,510,857, and the stock shows intraday range JPY 32.00–34.00. Investors are watching upcoming catalysts including R&D updates and the next earnings announcement scheduled for 20 May 2026. We use market, sector and balance-sheet data to connect those events to price and liquidity trends.